{"filing":{"accession_number":"0001104659-26-090423","cik":"0001971387","ticker":"LIMNW","company_name":"Liminatus Pharma, Inc.","form":"8-K","filing_date":"2026-08-04","report_date":"2026-08-03","primary_document":"tm2622207d1_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1971387/000110465926090423/tm2622207d1_8k.htm"},"events":[{"id":23660,"run_id":21395,"accession_number":"0001104659-26-090423","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"This is a clear disclosure of shareholder voting results from the 2026 Annual Meeting held on August 3, 2026, covering three proposals: election of directors, ratification of auditors, and approval of a reverse stock split with charter amendment. The filing directly corresponds to Item 5.07 and reports the final vote tallies for each matter, which is material to investors as it reflects stockholder decisions on governance and capital structure matters.","company_name":"Liminatus Pharma, Inc.","ticker":"LIMNW","filing_date":"2026-08-04","form":"8-K","submitted_at":null,"items":[{"id":23959,"accession_number":"0001104659-26-090423","item_number":"5.07","item_title":"Submission of Matters to a Vote of","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"This is a clear disclosure of shareholder voting results from the 2026 Annual Meeting held on August 3, 2026, covering three proposals: election of directors, ratification of auditors, and approval of a reverse stock split with charter amendment. The filing directly corresponds to Item 5.07 and reports the final vote tallies for each matter, which is material to investors as it reflects stockholder decisions on governance and capital structure matters.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-05T00:19:21.358788+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":23959,"accession_number":"0001104659-26-090423","item_number":"5.07","item_title":"Submission of Matters to a Vote of","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"This is a clear disclosure of shareholder voting results from the 2026 Annual Meeting held on August 3, 2026, covering three proposals: election of directors, ratification of auditors, and approval of a reverse stock split with charter amendment. The filing directly corresponds to Item 5.07 and reports the final vote tallies for each matter, which is material to investors as it reflects stockholder decisions on governance and capital structure matters.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-05T00:19:21.358788+00:00","company_name":"Liminatus Pharma, Inc.","ticker":"LIMNW","filing_date":"2026-08-04"}]}